Keystone Symposia: Drugs from Bugs: The Anti-Inflammatory Drugs of Tomorrow
03 April 2011 - 07 April 2011
Joint with Evolving Approaches to Early-Stage Drug Discovery
This meeting will bring together cross-disciplinary scientists to examine the growing opportunities for discovery of novel drugs from pathogens. Novel therapeutic strategies and new drugs can be developed by both understanding how pathogens modulate and usurp the immune system, and also by identifying the functional molecules from pathogens.
Snowbird Resort, Snowbird, Utah, US
http://www.keystonesymposia.org/11Z1
Keystone Symposia: Evolving Approaches to Early-Stage Drug Discovery
03 April 2011 - 07 April 2011
Joint with Drugs from Bugs: The Anti-Inflammatory Drugs of Tomorrow
This meeting will cover multiple challenges and opportunities facing drug discovery scientists, including diverse approaches to early-stage discovery in a resource-constrained environment, evolution of preclinical drug discovery in academia, evolution of drug leads/target validation from the NIH (MLPCN), funding early-stage/risky programs, external licensing of programs, and advances in biomarkers/imaging to enable target selection and rapid go/no go decisions.
Snowbird Resort, Snowbird, Utah, USA
http://www.keystonesymposia.org/11Z2
RNA Single Cell Biology-2011 Summit
04 April 2011 - 05 April 2011
This Year RNAi-2011-Meeting Will Be held in Conjunction with Single Cell Biology-2011-Meeting.
Two Tracks, One Venue
Hilton Garden Inn, 420 Totten Pond Road, Waltham 02451 USA
http://www.expressgenes.com/RNAi2011/main.html
Personalized Medicine Partnerships Conference
11 April 2011 - 13 April 2011
At Arrowhead’s 2011 Personalized Medicine Partnerships Conference, we will highlight key issues in forming partnerships and engage the best speakers to share their experiences with you. These key issues include:
• what pharmaceutical and diagnostic companies are looking for in a partner
• partnering challenges that arise within the realm of contractual negotiations, IP protection, regulatory affairs and commercialization
• benefits of partnerships, including more effective, efficient and safer clinical trials
• how and when to start a relationship, ie. discovery, clinical, post-commercialization?
• the risks of partnering
Washington, DC, USA
http://personalizedmedicinepartnerships.com/
Proteinase 2011
11 April 2011 - 12 April 2011
This symposium will cover progress in the design and synthesis of aspartic, serine, cysteine and metalloprotease inhibitors for a diverse range of target indications, while also covering a range of drug discovery activities: from Molecules to Medicines.
Novartis, Basel, Switzerland
http://www.rsc.org/ConferencesAndEvents/conference/alldetails.cfm?evid=106832
Pharma - Nutrition 2011
18 April 2011 - 20 April 2011
Pharma - Nutrition 2011 is the first and foremost platform entirely dedicated to the scientific interface between pharma and food. Key thought leaders from both pharmacology and food science communities will converge to discuss the latest research, concepts and applications of medical nutrition in patient treatment and disease management for the purpose of improving patient outcomes.
Amsterdam, The Netherlands
http://www.pharma-nutrition.com/